Human-centered disruptor recognized for efforts to remove the needle from inpatient blood collection, transforming a universally painful experience into a more humane, efficient standard of care
San Francisco, Calif. – Feb. 20, 2019 – Vascular access technology pioneer Velano Vascular has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2019 and to its Top 10 Most Innovative Companies in Biotech. Velano was recognized for its innovative approach to reimagining the status quo in medicine by removing the needle from blood collection.
More than one billion inpatient blood draws occur around the world every year, informing nearly 70% of all medical decisions. Yet this procedure is made more difficult and less efficient through the use of needles, a process that is further complicated by the rising incidence of Difficult Venous Access (DVA) patients due to age, obesity and chronic illness.
Velano’s award-winning PIVO™ needle-free blood collection device and its family of vascular access products combat the urgent challenge of vascular access globally through a new, more humane standard of care. Co-founded by a physician inventor and a chronic disease patient with a clinical fear of needles in 2012, Velano has expanded its one-stick hospitalization aim to dozens of U.S. hospitals and touched hundreds of thousands of lives in 2018 alone.
“Transforming the status quo and delivering a more humane standard of care is finding a receptive audience amongst caregivers, patients, and technologists, and those who view the world of medicine as ripe for change,” said Velano Chief Executive Eric M. Stone. “Our vision is to positively impact every human being on the planet through a more compassionate, efficient and fiscally responsible approach to the most common invasive procedure performed in hospitals every day.”
This year, Fast Company editors and writers sought out groundbreaking businesses across 35 industries and every region. The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. It provides both a snapshot and a road map for the future of innovation across the most dynamic sectors of the economy.